| Filed | Form | Issuer | Stake | Shares | Intent | |
|---|---|---|---|---|---|---|
| 2026-10-16 | SCHEDULE 13G | Frazier Life Sciences Acquisition Corp. IIFLSC | — | — | view → | |
| 2026-10-14 | SCHEDULE 13G | iBio, Inc.IBIO | — | — | view → | |
| 2026-10-07 | SCHEDULE 13G | OnKure Therapeutics, Inc.OKUR | — | — | view → | |
| 2026-10-05 | SCHEDULE 13G | Pyxis Oncology, Inc.PYXS | — | — | view → | |
| 2026-07-01 | SCHEDULE 13G/A | Pasithea Therapeutics Corp.KTTAW | — | — | view → | |
| 2026-07-01 | SCHEDULE 13G/A | Adial Pharmaceuticals, Inc.ADIL | — | — | view → | |
| 2026-06-24 | SCHEDULE 13G | Adial Pharmaceuticals, Inc.ADIL | — | — | view → | |
| 2026-06-17 | SCHEDULE 13G | Eloxx Pharmaceuticals, Inc.ELOX | — | — | view → |
Free. We email you when criteria match. One-click unsubscribe in every email.
Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.
See pricing →